Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.7 USD | -3.23% | -6.57% | -6.57% |
12/02 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
07/02 | Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bullish | Neutral |
Resistance | 3.450 | 3.450 | 3.450 |
Spread/Res. | -21.74% | -21.74% | -21.74% |
Spread/Supp. | +0.75% | +0.75% | +52.54% |
Support | 2.680 | 2.680 | 1.770 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- ACST Stock
- Charts Acasti Pharma Inc.